Kayne Anderson Rudnick Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.2M Sell
230,718
-16,065
-7% -$1.53M 0.07% 165
2025
Q4
$20M Buy
246,783
+4,847
+2% +$417K 0.05% 193
2025
Q3
$21.2M Sell
241,936
-1,060
-0.4% -$94.7K 0.05% 194
2025
Q2
$20.2M Buy
242,996
+50,092
+26% +$4.19M 0.05% 196
2025
Q1
$16.2M Sell
192,904
-181
-0.1% -$16.8K 0.04% 211
2024
Q4
$17.8M Sell
193,085
-1,455
-0.7% -$140K 0.04% 207
2024
Q3
$18.1M Buy
+194,540
New +$16.9M 0.04% 204

Other funds holding LMAT

Kayne Anderson Rudnick Investment Management's LMAT Position: Q1 2026 in Review

Kayne Anderson Rudnick Investment Management reduced its LeMaitre Vascular (LMAT) stake by 6.5% in Q1 2026, selling an estimated $1.53M and leaving 230,718 shares worth $25.2M. The position accounts for 0.07% of the portfolio, ranked #165.

Kayne Anderson Rudnick Investment Management first reported a position in LMAT in Q3 2024 and has held it in 7 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Kayne Anderson Rudnick Investment Management held 230,718 shares of LeMaitre Vascular worth $25.2M as of Q1 2026.
  • Kayne Anderson Rudnick Investment Management sold 16,065 LeMaitre Vascular shares in Q1 2026, an estimated $1.53M.
  • LeMaitre Vascular made up 0.07% of Kayne Anderson Rudnick Investment Management's portfolio in Q1 2026, its #165 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in LeMaitre Vascular in Q3 2024 and has held it in 7 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2026, filed 14 May 2026.